| D |
2026-03-23 |
2026-03-19 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
A - Grant |
$0.00 |
+32.5K |
139.9K |
+30% |
$0 |
|
2026-03-05 |
2026-03-03 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
F - Tax |
$20.99 |
-11.3K |
107.4K |
-10% |
-$237.5K |
|
2025-08-20 |
2025-07-01 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
F - Tax |
$6.84 |
-4,470 |
118.7K |
-4% |
-$30.6K |
|
2025-07-03 |
2025-03-01 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
F - Tax |
$7.92 |
-1,824 |
98.7K |
-2% |
-$14.4K |
|
2025-07-03 |
2025-07-01 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
A - Grant |
$0.00 |
+24.5K |
123.2K |
+25% |
$0 |
| D |
2025-03-18 |
2025-03-15 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
A - Grant |
$0.00 |
+63.8K |
100.5K |
+174% |
$0 |
| D |
2024-03-19 |
2024-03-15 |
GPCR |
Structure Therapeutics Inc. |
Ma Yingli |
CTO |
A - Grant |
$0.00 |
+36.7K |
36.7K |
New |
$0 |